person

Francesco P.

Country
Italy
Department
U.O.C. Ematologia - Istituto Nazionale dei Tumori Regina Elena

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
10
Sites with multiple studies

Has run more than one trial at 10 of 51 partner sites.

Specializations

Hematologic Oncology

This investigator specializes in the treatment of multiple myeloma, with particular focus on newly diagnosed cases. Their research encompasses innovative therapeutic approaches for patients eligible for autologous stem cell transplantation.

  • Novel combination therapies
  • Transplant-eligible multiple myeloma
  • Treatment optimization strategies

The investigator explores various therapeutic combinations including proteasome inhibitors and immunomodulatory agents for optimal patient outcomes.

Neurological Disorders

The investigator focuses on treating rare neurological conditions, particularly Ataxia Telangiectasia (A-T). Their work involves evaluating novel therapeutic approaches for managing neurological symptoms associated with this condition.

  • CNS symptom management
  • Neurological function assessment
  • Rare disease therapeutics

Their research emphasizes long-term safety and efficacy evaluation of innovative treatments for A-T patients.

Clinical Research Methodology

The investigator demonstrates expertise in conducting complex clinical trials, including randomized controlled studies and open-label extensions in both hematologic and neurological conditions.

  • Multi-center trial coordination
  • Long-term treatment evaluation
  • Safety and efficacy assessment

Their approach encompasses both interventional and observational research methodologies across different therapeutic areas.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.